Lisa Bhatt

Lisa Bhatt specializes in the clinical-grade manufacturing of autologous dendritic cell vaccines for cancer immunotherapy, developing optimized protocols for DC generation, antigen loading, and maturation that produce consistently potent immunogenic DCs. Her laboratory has established GMP-compliant manufacturing processes used in multiple clinical trials. She has contributed to standardizing DC vaccine quality control assays. Her manufacturing expertise is critical for translating DC vaccine research into reproducible clinical therapies.